Navi Raises $6.8M for FDA-Cleared Pediatric ECG Device Launch in US
Navi Medical Technologies raises A$6.8M to bring its FDA-cleared Neonav system to US children's hospitals, using real-time ECG to improve central line placement in neonates.
Healthcare entity
Every one of those 1 sits in a single category, medical-devices. US FDA is most often covered alongside Alex Newton, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. US FDA appears in 1 tracked Healthcare story from July 29, 2026.
Last mentioned: Jul 29, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, medical-devices. US FDA is most often covered alongside Alex Newton, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. US FDA appears in 1 tracked Healthcare story from July 29, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering US FDA. Shared-story counts are live from our verified record — not editorial picks.
Navi Medical Technologies raises A$6.8M to bring its FDA-cleared Neonav system to US children's hospitals, using real-time ECG to improve central line placement in neonates.
US FDA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.